Suppliers / Sieć Badawcza Łukasiewicz – Instytut Farmaceutyczny

Sieć Badawcza Łukasiewicz – Instytut Farmaceutyczny

Poland 40 employees Updated 9 July 2026

Sieć Badawcza Łukasiewicz – Instytut Farmaceutyczny is an API manufacturer based in Poland. It holds one valid CEP.

0
active US DMFs
1
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Warsaw, Poland Not on file

What they file, and where

Molecule Regulators Docs
Calcitriol EDQM 1

Also appears on these molecule pages

Questions about Sieć Badawcza Łukasiewicz – Instytut Farmaceutyczny

Does Sieć Badawcza Łukasiewicz – Instytut Farmaceutyczny hold a US DMF or a CEP?
Sieć Badawcza Łukasiewicz – Instytut Farmaceutyczny holds 1 valid CEP. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Sieć Badawcza Łukasiewicz – Instytut Farmaceutyczny manufacture?
1 registered site is on record, in Poland (Warsaw). Every site is listed on this page with the register it came from.
What does Sieć Badawcza Łukasiewicz – Instytut Farmaceutyczny make?
1 molecule is on record against Sieć Badawcza Łukasiewicz – Instytut Farmaceutyczny, including Calcitriol. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Sieć Badawcza Łukasiewicz – Instytut Farmaceutyczny comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability